Ladone Mary Kay 4

What Happened
Mary Kay Ladone, a director of Bioventus, had previously granted restricted stock units (RSUs) vest and convert into 32,282 shares on June 2, 2026 (reported as an M-code exercise/conversion). The filing shows a same-day disposition of those 32,282 shares. On June 3, 2026 she was recorded as receiving a new award of 25,146 RSUs (A-code). All reported transactions list a $0 per-share exercise/grant price because these entries involve RSU conversions and derivative awards rather than open-market cash purchases or sales.

Key Details

• Transaction dates and types:
  • 2026-06-02: Exercise/conversion of derivative (M) — 32,282 shares acquired at $0.00.
  • 2026-06-02: Disposal of 32,282 shares (derivative) at $0.00 (same day).
  • 2026-06-03: Grant/award (A) — 25,146 RSUs acquired at $0.00.
• Filing date: Form 4 filed 2026-06-04 (reports transactions dated 2026-06-02 and 06-03); filing appears timely.
• Shares owned after transaction: not specified in the filing.
• Footnotes:
  • F1: Each RSU represents a contingent right to receive one share of Class A common stock.
  • F2: The RSUs vested on June 2, 2026.
  • F3: The new RSUs vest on the earlier of the issuer’s first post-grant annual meeting or the first anniversary of grant, subject to continued board service.

Context
RSU vesting and conversion (reported here) typically reflect the settlement of previously granted equity awards. Same-day disposals following conversion are commonly reported when shares are withheld or transferred to satisfy tax or other withholding obligations; the filing shows no cash proceeds because these are derivative/award transactions. The June 3 entry is a fresh RSU grant subject to future vesting under the terms noted above.